Age, years, mean ± SD
|
51 ± 13
|
Gender, male, number (%)
|
181 (60.7%)
|
Regraft, number (%)
|
29 (9.0%)
|
Diabetes mellitus, number (%)
|
69 (23%)
|
End-stage renal disease
|
|
Polycystic kidney disease, number (%)
|
55 (19%)
|
Glomerulonephritis, number (%)
|
85 (29%)
|
Diabetes mellitus, number (%)
|
50 (17%)
|
Recipient weight, kg, mean ± SD
|
78 ± 17
|
Recipient body mass index, kg/m2, mean ± SD
|
28 ± 5
|
Blood transfusion, never, number (%)
|
205 (69%)
|
Human leukocyte antigen mismatch, mean ± SD
|
4.1 ± 1.4
|
Dialysis duration, days, median (IQR)
|
819 (419, 1462)
|
Calculated panel reactive antibody, %, median (IQR)
|
0 (0, 8)
|
Cold ischemic time, hours, median (IQR)
|
12 (8, 16)
|
Anastamosis time, minutes, median (IQR)
|
30 (24, 45)
|
Donation after circulatory death, number (%)
|
16 (5.4%)
|
Donor cause of death
|
|
Anoxia, number (%)
|
24 (8%)
|
Cerebrovascular event, number (%)
|
189 (62%)
|
Donor age years, mean ± SD
|
47 ± 17
|
Donor male, number (%)
|
135 (45%)
|
Donor weight kg, mean ± SD
|
76 ± 19
|
Donor body mass index kg/m2, mean ± SD
|
27 ± 6
|
Donor creatinine μmol/L, mean ± SD
|
67 ± 31
|
Delayed graft function, number (%)
|
56 (18.8%)
|
Days in hospital, days, median (IQR)
|
9 (7, 14)
|
Creatinine day 7, μmol/L, median (IQR) |
168 (125, 314) |